LON:4BB 4basebio (4BB) Share Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free 4BB Stock Alerts GBX 1,120 +50.00 (+4.67%) (As of 04/25/2024 ET) Add Compare Share Share Today's Range 1,050▼ 1,12050-Day Range 720▼ 1,07052-Week Range 492▼ 1,120Volume849 shsAverage Volume3,080 shsMarket Capitalization£143.47 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsInsider TradesStock AnalysisChartCompetitorsInsider Trades Get 4basebio alerts: Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About 4basebio4basebio PLC engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and targeted non-viral vector solutions in the United States, Europe, and internationally. It provides AVV and Lentivirus manufacturing services for use in gene therapies and vaccines. The company offers access to its targeted non-viral delivery platform, Hermes. It serves biotech, pharma, and contract development and manufacturing organization. The company was formerly known as 4basebio UK Societas and changed its name to 4basebio PLC in July 2021. 4basebio PLC was founded in 2008 and is based in Cambridge, the United Kingdom.Read More 4BB Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart 4BB Stock News HeadlinesMay 13, 2023 | finance.yahoo.com4basebio Full Year 2022 Earnings: Revenues DisappointApril 3, 2023 | finanznachrichten.de4basebio Plc - New lease and expansion of manufacturing capacityApril 25, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.February 9, 2023 | finanznachrichten.de4basebio Plc - Exercise of Options and Issue of EquitySeptember 30, 2022 | uk.finance.yahoo.com4basebio Plc - Half-year ReportJune 10, 2022 | uk.finance.yahoo.com4basebio Plc - Research CollaborationJune 9, 2022 | uk.finance.yahoo.com4basebio Plc - Result of AGMMay 11, 2022 | uk.finance.yahoo.com4basebio Plc - Director/PDMR ShareholdingApril 25, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.April 27, 2022 | uk.finance.yahoo.com4basebio Plc - Joint Development Agreement with Heqet TherapeuticsJanuary 5, 2022 | investing.com4BASEBIO UK SOCIETAS (4BB)October 20, 2021 | finance.yahoo.comWhat Type Of Shareholders Make Up 4basebio PLC's (LON:4BB) Share Registry?See More Headlines Receive 4BB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for 4basebio and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:4BB CUSIPN/A CIKN/A Webwww.4basebio.com Phone44 1223 967 943FaxN/AEmployees78Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.51) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-6,280,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-97.29% Return on Assets-35.08% Debt Debt-to-Equity Ratio201.47 Current Ratio3.41 Quick Ratio3.52 Sales & Book Value Annual Sales£311,000.00 Price / Sales452.67 Cash FlowGBX 68.35 per share Price / Cash Flow16.08 Book ValueGBX 28 per share Price / Book39.25Miscellaneous Outstanding Shares12,810,000Free FloatN/AMarket Cap£140.78 million OptionableNot Optionable Beta1.10 Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesDr. Heikki Lanckriet Ph.D. (Age 47)CEO, Chief Scientific Officer & Executive Director Comp: $448.9kMr. David Roth (Age 57)CFO, Company Secretary & Executive Director Comp: $323.1kMr. Mark CooperHead of ManufacturingKey CompetitorsCircassia GroupLON:CIRAvacta GroupLON:AVCTTiziana Life SciencesLON:TILSVerseonLON:VSNFutura MedicalLON:FUMView All Competitors 4BB Stock Analysis - Frequently Asked Questions How have 4BB shares performed in 2024? 4basebio's stock was trading at GBX 680 at the beginning of 2024. Since then, 4BB shares have increased by 64.7% and is now trading at GBX 1,120. View the best growth stocks for 2024 here. How do I buy shares of 4basebio? Shares of 4BB stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:4BB) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsYour Money is Not SafeAmerican AlternativeThe AI stock to buy right nowStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 4basebio PLC Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
